Index of /facts/surv_20220425
Name Last modified Size Description
Parent Directory -
sC72__G-ICD-10-C72-Rueckenmarkstumor-Survival.pdf 2022-04-25 16:16 184K
sC26__G-ICD-10-C26-Tumor-sonst.-Verdauungsorgane-Survival.pdf 2022-04-25 16:15 185K
sC75__G-ICD-10-C75-Tumor-sonstiger-endokriner-Druesen-Survival.pdf 2022-04-25 16:16 195K
sC47__G-ICD-10-C47-Neubildung-peripherer-Nerven-Survival.pdf 2022-04-25 16:15 195K
sC46__G-ICD-10-C46-Kaposi-Sarkom-Survival.pdf 2022-04-25 16:15 196K
sD33__G-ICD-10-D33-Gutart.-Neub.-d.-ZNS-Survival.pdf 2022-04-25 16:16 211K
sC96__G-ICD-10-C96-Sonst.-boesartige-Systemerkrankung-Survival.pdf 2022-04-25 16:16 213K
sD45__G-ICD-10-D45-Polycythaemia-vera-Survival.pdf 2022-04-25 16:17 214K
sC70__G-ICD-10-C70-Meningentumor-Survival.pdf 2022-04-25 16:16 217K
sD32__G-ICD-10-D32-Gutart.-Neub.-d.-Meningen-Survival.pdf 2022-04-25 16:16 218K
sC37__G-ICD-10-C37-Thymus-Tumor-Survival.pdf 2022-04-25 16:15 220K
sMCC__G-MCC-Merkelzellkarzinom-Survival.pdf 2022-04-27 17:14 223K
sD46__G-ICD-10-D46-Myelodysplastisches-Syndrom-Survival.pdf 2022-04-25 16:17 226K
sD03__G-ICD-10-D03-Melanoma-in-situ-Survival.pdf 2022-04-25 16:16 232K
sD391_G-ICD-10-D39.1-Ovar-Borderline-Survival.pdf 2022-04-25 16:17 232K
shPNETG-P-NET-Neuroendokr.-Pankreastu.-Survival.pdf 2022-04-27 17:14 233K
sD3748G-ICD-10-D37-D48-NPL-unbek.-Verhalten-Survival.pdf 2022-04-25 16:17 235K
sC80__G-ICD-10-C80-CUP-Syndrom-Survival.pdf 2022-04-25 16:16 237K
sD05f_G-ICD-10-D05-Mammakarzinom-i.s.-Frauen-Survival.pdf 2022-04-25 16:16 238K
sMPDf_G-M.-Paget-der-Brust-Survival.pdf 2022-04-27 17:14 241K
sD0009G-ICD-10-D00-D09-In-situ-Neubildungen-Survival.pdf 2022-04-25 16:16 241K
sC00__G-ICD-10-C00-Lippentumor-Survival.pdf 2022-04-25 16:14 251K
sC837_G-ICD-10-C83.7-Burkitt-Lymphom-Survival.pdf 2022-04-25 16:16 254K
sD04__G-ICD-10-D04-Ca.-i.s.-Haut-Survival.pdf 2022-04-25 16:16 256K
sC450_G-ICD-10-C45.0-Pleuramesotheliom-Survival.pdf 2022-04-25 16:15 260K
sC74__G-ICD-10-C74-Nebennierentumor-Survival.pdf 2022-04-25 16:16 261K
sC86__G-ICD-10-C86-Weitere-spezif.-T-NK-Zell-Lymphome-Survival.pdf 2022-04-25 16:16 262K
sC45__G-ICD-10-C45-Mesotheliom-Survival.pdf 2022-04-25 16:15 262K
sC9395G-ICD-10-C93-C95-Sonst.-Leukaemien-Survival.pdf 2022-04-25 16:16 265K
sC52__G-ICD-10-C52-Vaginalkarzinom-Survival.pdf 2022-04-25 16:15 265K
sC60__G-ICD-10-C60-Peniskarzinom-Survival.pdf 2022-04-25 16:15 265K
sC50m_G-ICD-10-C50-Mammakarzinom-Maenner-Survival.pdf 2022-04-25 16:15 266K
sC06__G-ICD-10-C06-Tumor-des-Mundes-o.n.A.-Survival.pdf 2022-04-25 16:14 266K
sC11__G-ICD-10-C11-Nasopharynxtumor-Survival.pdf 2022-04-25 16:15 266K
sC910_G-ICD-10-C91.0-Akute-lymphat.-Leukaemie-Survival.pdf 2022-04-25 16:16 267K
sC03__G-ICD-10-C03-Zahnfleischtumor-Survival.pdf 2022-04-25 16:14 268K
shBNETG-BNET-Neuroendokr.-Lungentu.-Survival.pdf 2022-04-27 17:14 268K
sC221_G-ICD-10-C22.1-Cholangiokarzinom-Survival.pdf 2022-04-25 16:15 268K
sC05__G-ICD-10-C05-Gaumentumor-Survival.pdf 2022-04-25 16:14 268K
sC9212G-ICD-10-C92.1-C92.2-Chron.-myel.-Leukaemie-Survival.pdf 2022-04-25 16:16 269K
shGISTG-GIST-Gastroint.-Stromatumor-Survival.pdf 2022-04-27 17:14 271K
sD06__G-ICD-10-D06-Ca.-i.s.-Cervix-Survival.pdf 2022-04-25 16:16 272K
sC66__G-ICD-10-C66-Uretertumor-Survival.pdf 2022-04-25 16:16 274K
sC69M_G-ICD-10-C69-Augenmelanom-Survival.pdf 2022-04-25 16:16 274K
sC73A_G-ICD-10-C73-Anaplastisches-Schilddruesenca.-Survival.pdf 2022-04-25 16:16 275K
sC57__G-ICD-10-C57-Tumor-sonst.-weibl.-Genitalorgane-Survival.pdf 2022-04-25 16:15 276K
sC38__G-ICD-10-C38-Herz-Mediastinum-Pleura-Survival.pdf 2022-04-25 16:15 276K
sC0708G-ICD-10-C07-C08-Speicheldruesentumor-Survival.pdf 2022-04-25 16:14 277K
sC62__G-ICD-10-C62-Hodentumor-Survival.pdf 2022-04-25 16:15 279K
sC48__G-ICD-10-C48-Peritonealtumor-Survival.pdf 2022-04-25 16:15 279K
sC69__G-ICD-10-C69-Augentumor-Survival.pdf 2022-04-25 16:16 280K
sC01__G-ICD-10-C01-Zungengrundtumor-Survival.pdf 2022-04-25 16:14 280K
sC7780G-ICD-10-C77-C80-Sekundaere-und-unbekannte-Lokalisationen-Survival.pdf 2022-04-25 16:16 281K
sC181_G-ICD-10-C18.1-Appendixkarzinom-Survival.pdf 2022-04-25 16:15 282K
sC7680G-ICD-10-C76-C80-Sekundaere-und-unspezifische-Lokalisationen-Survival.pdf 2022-04-25 16:16 282K
sC920_G-ICD-10-C92.0-Akute-myel.-Leukaemie-Survival.pdf 2022-04-25 16:16 284K
shGNETG-GI-NET-Gastroint.-neuroend.-Tumor-Survival.pdf 2022-04-27 17:14 284K
sCSCC_G-cSCC-Plattenepithelca.-Haut-Survival.pdf 2022-04-25 16:16 285K
sC84__G-ICD-10-C84-Reifzellige-T-NK-Zell-L.-Survival.pdf 2022-04-25 16:16 285K
sC14__G-ICD-10-C14-Tumor-des-Mundes-u.-Pharynx-Survival.pdf 2022-04-25 16:15 288K
sC71A_G-ICD-10-C71-Astrozytom-I-III-Survival.pdf 2022-04-25 16:16 289K
sC92__G-ICD-10-C92-Myeloische-Leukaemie-Survival.pdf 2022-04-25 16:16 290K
sC884_G-ICD-10-C88.4-MALT-Lymphom-Survival.pdf 2022-04-25 16:16 293K
sC900_G-ICD-10-C90.0-Multiples-Myelom-Survival.pdf 2022-04-25 16:16 294K
sC4041G-ICD-10-C40-C41-Knochentumor-Survival.pdf 2022-04-25 16:15 294K
sC81__G-ICD-10-C81-Hodgkin-Lymphom-Survival.pdf 2022-04-25 16:16 294K
shDNETG-GEP-NET-Gastr.ent.pankr.-neuroend.-Tumor-Survival.pdf 2022-04-27 17:14 296K
sC831_G-ICD-10-C83.1-Mantelzell-Lymphom-Survival.pdf 2022-04-25 16:16 296K
sC911_G-ICD-10-C91.1-Chron.-lymphat.-Leukaemie-Survival.pdf 2022-04-25 16:16 298K
sC04__G-ICD-10-C04-Mundboden-Survival.pdf 2022-04-25 16:14 298K
sC3031G-ICD-10-C30-C31-Nasenhoehle-Nasennebenhoehlen-Mittelohr-Survival.pdf 2022-04-25 16:15 298K
sD0941G-ICD-10-D09.0-D41.4-Blasentumor-Survival.pdf 2022-04-25 16:16 298K
sC51__G-ICD-10-C51-Vulvakarzinom-Survival.pdf 2022-04-25 16:15 300K
sC73M_G-ICD-10-C73-Medullaeres-Schilddruesenca.-Survival.pdf 2022-04-25 16:16 301K
sC82__G-ICD-10-C82-Follik.-Lymphom-Survival.pdf 2022-04-25 16:16 302K
sC02__G-ICD-10-C02-Zungentumor-ohne-Zungengrund-Survival.pdf 2022-04-25 16:14 303K
sC91__G-ICD-10-C91-Lymphatische-Leukaemie-Survival.pdf 2022-04-25 16:16 304K
sC09__G-ICD-10-C09-Tonsille-Survival.pdf 2022-04-25 16:14 305K
sC71G_G-ICD-10-C71-Glioblastom-Survival.pdf 2022-04-25 16:16 306K
sC85__G-ICD-10-C85-Non-Hodgkin-Lymphom-o.n.A.-Survival.pdf 2022-04-25 16:16 308K
sC65__G-ICD-10-C65-Nierenbeckentumor-Survival.pdf 2022-04-25 16:16 309K
sC17__G-ICD-10-C17-Duenndarmkarzinom-Survival.pdf 2022-04-25 16:15 312K
sC8890G-ICD-10-C88-C90-Immunprolif.-Neubildung-Survival.pdf 2022-04-25 16:16 314K
sC90__G-ICD-10-C90-Plasmozytom-Survival.pdf 2022-04-25 16:16 315K
sC23__G-ICD-10-C23-Gallenblasentumor-Survival.pdf 2022-04-25 16:15 316K
sC1213G-ICD-10-C12-C13-Hypopharynxtumor-Survival.pdf 2022-04-25 16:15 318K
sC73F_G-ICD-10-C73-Follikulaeres-Schilddruesenca.-Survival.pdf 2022-04-25 16:16 320K
sC44__G-ICD-10-C44-Sonst.-Haut-Survival.pdf 2022-04-25 16:15 324K
sC71__G-ICD-10-C71-Gehirntumor-Survival.pdf 2022-04-25 16:16 327K
sC914aG-ICD-10-C91.0-C92.0-C94.4-Akute-Leukaemien-Survival.pdf 2022-04-25 16:16 327K
sC7072G-ICD-10-C70-C72-Gehirn-u.-Nervensystem-Tumor-Survival.pdf 2022-04-25 16:16 330K
sC21__G-ICD-10-C21-Analkarzinom-Survival.pdf 2022-04-25 16:15 330K
sC4549G-ICD-10-C45-C49-Mesothel.-u.-Weichteiltu.-Survival.pdf 2022-04-25 16:15 331K
sC73P_G-ICD-10-C73-Papillaeres-Schilddruesenca.-Survival.pdf 2022-04-25 16:16 335K
sC833_G-ICD-10-C83.3-Diff.-grosszell.-B-Zell-Lymphom-Survival.pdf 2022-04-25 16:16 336K
sC49__G-ICD-10-C49-Weichteiltumor-Survival.pdf 2022-04-25 16:15 338K
sC83__G-ICD-10-C83-Nicht-follik.-Lymphom-Survival.pdf 2022-04-25 16:16 339K
sC24__G-ICD-10-C24-Gallenwegstumor-Survival.pdf 2022-04-25 16:15 345K
sC220_G-ICD-10-C22.0-Leberzellkarzinom-Survival.pdf 2022-04-25 16:15 346K
sC0910G-ICD-10-C09-C10-Oropharynxtumor-Survival.pdf 2022-04-25 16:14 347K
sC32__G-ICD-10-C32-Larynxkarzinom-Survival.pdf 2022-04-25 16:15 350K
sC22__G-ICD-10-C22-Leberkarzinom-Survival.pdf 2022-04-25 16:15 360K
sC9195G-ICD-10-C91-C95-Leukaemien-Survival.pdf 2022-04-25 16:16 362K
sC53__G-ICD-10-C53-Zervixkarzinom-Survival.pdf 2022-04-25 16:15 372K
sC8286G-ICD-10-C82-C86-NHL-Survival.pdf 2022-04-25 16:16 375K
sC73__G-ICD-10-C73-Schilddruesenkarzinom-Survival.pdf 2022-04-25 16:16 378K
sC0106G-ICD-10-C01-C06-Mundbereichtumor-Survival.pdf 2022-04-25 16:14 381K
sC0914G-ICD-10-C09-C14-Pharynxkarzinom-Survival.pdf 2022-04-25 16:15 385K
shST__G-Weichteiltumor-klassif.-nach-Histologie-Survival.pdf 2022-04-27 17:14 388K
sC34S_G-ICD-10-C34-Kleinzell.-BC-Survival.pdf 2022-04-25 16:15 391K
sC43__G-ICD-10-C43-Malignes-Melanom-Survival.pdf 2022-04-25 16:15 394K
sC15__G-ICD-10-C15-Oesophaguskarzinom-Survival.pdf 2022-04-25 16:15 395K
sC25__G-ICD-10-C25-Pankreaskarzinom-Survival.pdf 2022-04-25 16:15 404K
sC56__G-ICD-10-C56-Ovarialtumor-Survival.pdf 2022-04-25 16:15 408K
sC6466G-ICD-10-C64-C66-C68-Harnorgantumor-Survival.pdf 2022-04-25 16:16 410K
sC54__G-ICD-10-C54-Corpuskarzinom-Survival.pdf 2022-04-25 16:15 413K
sC8196G-ICD-10-C81-C96-Systemische-Neubildungen-Survival.pdf 2022-04-25 16:16 416K
sC5355G-ICD-10-C53-C55-Uteruskarzinom-Survival.pdf 2022-04-25 16:15 420K
sC64__G-ICD-10-C64-Nierenkarzinom-Survival.pdf 2022-04-25 16:16 424K
sC6468G-ICD-10-C64-C68-Harnorgantumor-Survival.pdf 2022-04-25 16:16 434K
sC0014G-ICD-10-C00-C14-HNO-Tumoren-Survival.pdf 2022-04-25 16:14 442K
sC67__G-ICD-10-C67-Blasenkarzinom-Survival.pdf 2022-04-25 16:16 454K
sC0032G-ICD-10-C00-C14-C30-C32-HNO-Tumoren-Survival.pdf 2022-04-25 16:14 464K
sC5158G-ICD-10-C51-C58-Gyn.-Tumoren-Survival.pdf 2022-04-25 16:15 467K
sC16__G-ICD-10-C16-Magenkarzinom-Survival.pdf 2022-04-25 16:15 471K
sC34N_G-ICD-10-C34-Nicht-kleinzell.-BC-Survival.pdf 2022-04-25 16:15 482K
sC1920G-ICD-10-C19-C20-Rektumkarzinom-Survival.pdf 2022-04-25 16:15 496K
sC6068G-ICD-10-C60-C68-Urolog.-Tumoren-Survival.pdf 2022-04-25 16:15 499K
sC1526G-ICD-10-C15-C26-GI-Tumoren-Survival.pdf 2022-04-25 16:15 536K
sC61__G-ICD-10-C61-Prostatakarzinom-Survival.pdf 2022-04-25 16:15 537K
sC34__G-ICD-10-C34-Lungentumor-Survival.pdf 2022-04-25 16:15 538K
sC3334G-ICD-10-C33-C34-Lungentumor-Survival.pdf 2022-04-25 16:15 538K
sC18__G-ICD-10-C18-Kolonkarzinom-Survival.pdf 2022-04-25 16:15 560K
sC50f_G-ICD-10-C50-Mammakarzinom-Frauen-Survival.pdf 2022-04-25 16:15 573K
sC1821G-ICD-10-C18-C21-Darmtumor-Survival.pdf 2022-04-25 16:15 599K
sC1820G-ICD-10-C18-C20-Darmtumor-Survival.pdf 2022-04-25 16:15 611K
sC0096G-ICD-10-C00-C96.9-Alle-Tumoren-ohne-C44-Survival.pdf 2022-04-25 16:14 831K